Cargando…

The Amuvatinib Derivative, N-(2H-1,3-Benzodioxol-5-yl)-4-{thieno[3,2-d]pyrimidin-4-yl}piperazine-1-carboxamide, Inhibits Mitochondria and Kills Tumor Cells under Glucose Starvation

Glucose levels inside solid tumors are low as compared with normal surrounding tissue, forcing tumor cells to reprogram their metabolism to adapt to such low glucose conditions. Unlike normal tissue, tumor cells experience glucose starvation, making the targeting of pathways supporting survival duri...

Descripción completa

Detalles Bibliográficos
Autores principales: Marciano, Ran, Ben David, Hila, Akabayov, Barak, Rotblat, Barak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036964/
https://www.ncbi.nlm.nih.gov/pubmed/32033217
http://dx.doi.org/10.3390/ijms21031041
_version_ 1783500316602269696
author Marciano, Ran
Ben David, Hila
Akabayov, Barak
Rotblat, Barak
author_facet Marciano, Ran
Ben David, Hila
Akabayov, Barak
Rotblat, Barak
author_sort Marciano, Ran
collection PubMed
description Glucose levels inside solid tumors are low as compared with normal surrounding tissue, forcing tumor cells to reprogram their metabolism to adapt to such low glucose conditions. Unlike normal tissue, tumor cells experience glucose starvation, making the targeting of pathways supporting survival during glucose starvation an interesting therapeutic strategy in oncology. Using high-throughput screening, we previously identified small molecules that selectively kill cells exposed to glucose starvation. One of the identified compounds was the kinase inhibitor amuvatinib. To identify new molecules with potential antineoplastic activity, we procured 12 amuvatinib derivatives and tested their selective toxicity towards glucose-starved tumor cells. One of the amuvatinib derivatives, N-(2H-1,3-benzodioxol-5-yl)-4-{thieno[3,2-d]pyrimidin-4-yl}piperazine-1-carboxamide, termed compound 6, was found to be efficacious in tumor cells experiencing glucose starvation. In line with the known dependence of glucose-starved cells on the mitochondria, compound 6 inhibits mitochondrial membrane potential. These findings support the concept that tumor cells are dependent on mitochondria under glucose starvation, and bring forth compound 6 as a new molecule with potential antitumor activity for the treatment of glucose-starved tumors.
format Online
Article
Text
id pubmed-7036964
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70369642020-03-11 The Amuvatinib Derivative, N-(2H-1,3-Benzodioxol-5-yl)-4-{thieno[3,2-d]pyrimidin-4-yl}piperazine-1-carboxamide, Inhibits Mitochondria and Kills Tumor Cells under Glucose Starvation Marciano, Ran Ben David, Hila Akabayov, Barak Rotblat, Barak Int J Mol Sci Article Glucose levels inside solid tumors are low as compared with normal surrounding tissue, forcing tumor cells to reprogram their metabolism to adapt to such low glucose conditions. Unlike normal tissue, tumor cells experience glucose starvation, making the targeting of pathways supporting survival during glucose starvation an interesting therapeutic strategy in oncology. Using high-throughput screening, we previously identified small molecules that selectively kill cells exposed to glucose starvation. One of the identified compounds was the kinase inhibitor amuvatinib. To identify new molecules with potential antineoplastic activity, we procured 12 amuvatinib derivatives and tested their selective toxicity towards glucose-starved tumor cells. One of the amuvatinib derivatives, N-(2H-1,3-benzodioxol-5-yl)-4-{thieno[3,2-d]pyrimidin-4-yl}piperazine-1-carboxamide, termed compound 6, was found to be efficacious in tumor cells experiencing glucose starvation. In line with the known dependence of glucose-starved cells on the mitochondria, compound 6 inhibits mitochondrial membrane potential. These findings support the concept that tumor cells are dependent on mitochondria under glucose starvation, and bring forth compound 6 as a new molecule with potential antitumor activity for the treatment of glucose-starved tumors. MDPI 2020-02-04 /pmc/articles/PMC7036964/ /pubmed/32033217 http://dx.doi.org/10.3390/ijms21031041 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Marciano, Ran
Ben David, Hila
Akabayov, Barak
Rotblat, Barak
The Amuvatinib Derivative, N-(2H-1,3-Benzodioxol-5-yl)-4-{thieno[3,2-d]pyrimidin-4-yl}piperazine-1-carboxamide, Inhibits Mitochondria and Kills Tumor Cells under Glucose Starvation
title The Amuvatinib Derivative, N-(2H-1,3-Benzodioxol-5-yl)-4-{thieno[3,2-d]pyrimidin-4-yl}piperazine-1-carboxamide, Inhibits Mitochondria and Kills Tumor Cells under Glucose Starvation
title_full The Amuvatinib Derivative, N-(2H-1,3-Benzodioxol-5-yl)-4-{thieno[3,2-d]pyrimidin-4-yl}piperazine-1-carboxamide, Inhibits Mitochondria and Kills Tumor Cells under Glucose Starvation
title_fullStr The Amuvatinib Derivative, N-(2H-1,3-Benzodioxol-5-yl)-4-{thieno[3,2-d]pyrimidin-4-yl}piperazine-1-carboxamide, Inhibits Mitochondria and Kills Tumor Cells under Glucose Starvation
title_full_unstemmed The Amuvatinib Derivative, N-(2H-1,3-Benzodioxol-5-yl)-4-{thieno[3,2-d]pyrimidin-4-yl}piperazine-1-carboxamide, Inhibits Mitochondria and Kills Tumor Cells under Glucose Starvation
title_short The Amuvatinib Derivative, N-(2H-1,3-Benzodioxol-5-yl)-4-{thieno[3,2-d]pyrimidin-4-yl}piperazine-1-carboxamide, Inhibits Mitochondria and Kills Tumor Cells under Glucose Starvation
title_sort amuvatinib derivative, n-(2h-1,3-benzodioxol-5-yl)-4-{thieno[3,2-d]pyrimidin-4-yl}piperazine-1-carboxamide, inhibits mitochondria and kills tumor cells under glucose starvation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036964/
https://www.ncbi.nlm.nih.gov/pubmed/32033217
http://dx.doi.org/10.3390/ijms21031041
work_keys_str_mv AT marcianoran theamuvatinibderivativen2h13benzodioxol5yl4thieno32dpyrimidin4ylpiperazine1carboxamideinhibitsmitochondriaandkillstumorcellsunderglucosestarvation
AT bendavidhila theamuvatinibderivativen2h13benzodioxol5yl4thieno32dpyrimidin4ylpiperazine1carboxamideinhibitsmitochondriaandkillstumorcellsunderglucosestarvation
AT akabayovbarak theamuvatinibderivativen2h13benzodioxol5yl4thieno32dpyrimidin4ylpiperazine1carboxamideinhibitsmitochondriaandkillstumorcellsunderglucosestarvation
AT rotblatbarak theamuvatinibderivativen2h13benzodioxol5yl4thieno32dpyrimidin4ylpiperazine1carboxamideinhibitsmitochondriaandkillstumorcellsunderglucosestarvation
AT marcianoran amuvatinibderivativen2h13benzodioxol5yl4thieno32dpyrimidin4ylpiperazine1carboxamideinhibitsmitochondriaandkillstumorcellsunderglucosestarvation
AT bendavidhila amuvatinibderivativen2h13benzodioxol5yl4thieno32dpyrimidin4ylpiperazine1carboxamideinhibitsmitochondriaandkillstumorcellsunderglucosestarvation
AT akabayovbarak amuvatinibderivativen2h13benzodioxol5yl4thieno32dpyrimidin4ylpiperazine1carboxamideinhibitsmitochondriaandkillstumorcellsunderglucosestarvation
AT rotblatbarak amuvatinibderivativen2h13benzodioxol5yl4thieno32dpyrimidin4ylpiperazine1carboxamideinhibitsmitochondriaandkillstumorcellsunderglucosestarvation